KIROMIC BIOPHARMA
Kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules. Kiromic aims to develop clinical diagnostic tools for rapid detection of cancer-associated antigens, which may translate into earlier diagnosis and accurate monitoring of response to cancer treatments. Their cancer-associated biomarkers also allow for the design and development of personalized, cancer-specific targeted immunotherapy strategies that may improve patient outcomes and result in less suffering and longer survival times.
KIROMIC BIOPHARMA
Industry:
Bioinformatics Biopharma Biotechnology Health Care Life Science Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.kiromic.com
Total Employee:
11+
Status:
Active
Contact:
806-252-5845
Total Funding:
53.24 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
ImmunoBiochem Corporation
ImmunoBiochem is developing novel tumor microenvironment-targeted biological therapeutics for solid tumor indications.
Nurix Therapeutics
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Current Advisors List
Board_member
2020-01-01
Current Employees Featured
Karen R. Reeves, MD Director @ Kiromic Biopharma
Director
2022-02-01
Maurizio Chiriva-Internati Chief Executive Officer & Founder @ Kiromic Biopharma
Chief Executive Officer & Founder
2016-02-01
Leonardo Mirandola Chief Scientific Officer @ Kiromic Biopharma
Chief Scientific Officer
2022-07-01
Daniel Clark Interim Chief Financial Officer @ Kiromic Biopharma
Interim Chief Financial Officer
2021-10-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-06-14 | In Silico Solutions | In Silico Solutions acquired by Kiromic Biopharma | N/A |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-12 | Kiromic BioPharma Appoints Leonardo Mirandola, Ph.D. as Chief Scientific Officer |
| 2021-10-05 | Kiromic BioPharma Announces Chief Financial Officer Transition |
Official Site Inspections
http://www.kiromic.com Semrush global rank: 6.92 M Semrush visits lastest month: 694
- Host name: host2001.hostmonster.com
- IP address: 67.20.76.53
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Kiromic Biopharma"
Kiromic Biopharma - Crunchbase Company Profile & Funding
Kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and …See details»
Kiromic Company Profile | Management and Employees List
Kiromic is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of g amma delta T-cells to target solid cancers. …See details»
KIROMIC, LLC - VentureRadar
" Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence (AI) platform to discover and develop cell and …See details»
Kiromic Biopharma - Org Chart, Teams, Culture & Jobs - The Org
Kiromic Biopharma is an immuno-oncology, target discovery, and gene editing company developing highly effective and safe tumor-specific cancer engineered immunotherapies to …See details»
Working At Kiromic: Company Overview and Culture - Zippia
Kiromic is a small professional company based in Houston, TX with only 50 employees and an annual revenue of $1.0B. Kiromic's Mission Statement Test products to be created by the joint …See details»
Kiromic - Golden
Organization. Company attributes. Industry. Molecular biology. 0. Bioinformatics. Healthcare. Pharmaceutical industry. Life science. ... Kiromic BioPharma, Inc. is an immuno-oncology …See details»
Kiromic Biopharma Company Profile - Office Locations ... - Craft
Sep 20, 2024 Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of …See details»
Board of Directors - Kiromic BioPharma, Inc.
Mr. Bersani has served as a member of our Board since June 2020. The Company appointed Mr. Bersani Chief Executive Officer effective May 10, 2022.See details»
Overview - Kiromic
In order to overcome this challenge, Kiromic BioPharma, Inc. has developed a number of therapies to equip the immune system with the right tools for fighting cancer. Acute …See details»
Kiromic BioPharma Announces Changes in Management, Board of …
Jan 27, 2022 Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence (AI) platform to discover and …See details»
Kiromic - Company Profile - Tracxn
Dec 5, 2024 Kiromic - Developer of small molecules-based therapeutic solutions for the treatment of cancer. Public Company. Raised a total funding of $135K over 1 round. Founded …See details»
Kiromic Company Profile 2024: Stock Performance & Earnings
Kiromic General Information Description. Kiromic BioPharma Inc is a biotechnology company. It is an artificial intelligence (AI) driven, end-to-end allogeneic cell therapy company, currently …See details»
Leadership - Kiromic
Before joining Kiromic, Dr. Mirandola was a post-doctoral research scientist at Texas Tech University Health Sciences Center. He earned an M.S. in Medical Biotechnologies and a Ph.D. …See details»
Kiromic BioPharma, Inc.
Kiromic BioPharma, Inc. (Exact name of registrant as specified in its charter) De l aware 46-4762913 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer …See details»
Kiromic Biopharma - Contacts, Employees, Board Members
Organization. Kiromic Biopharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Kiromic Biopharma has 1 …See details»
SEC.gov | SEC Charges Kiromic BioPharma and Two Former C-Suite ...
Dec 3, 2024 The Securities and Exchange Commission today filed settled charges against Houston-based biotherapeutics company Kiromic BioPharma, Inc., its former CEO, Maurizio …See details»
Kiromic Biopharma settles SEC charges over misleading investors ...
Dec 3, 2024 The SEC said Kiromic was not ordered to pay a civil penalty because the company had self-reported the incident, and Chiriva and Tontat agreed to pay civil penalties of $125,000 …See details»
Kiromic BioPharma Reports Fourth Quarter and Full-Year 2021 …
Dec 31, 2021 Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND ® artificial intelligence (AI) platform to discover and …See details»
Drug Development Pipeline - Kiromic
First patient Nov 2023 FTD Aug 2024 Expansion phase started in Sep 2024: Isocel™ Alone or in combination with Low-Dose Radiation* Allogeneic, off-the-shelf, Viral vector-free GDT CAR-T …See details»